About fremanezumab
Calcitonin gene-related peptide antagonist
Used for
- Prevention of migraine in adults
Usual adult dose
225 mg under the skin monthly, or 675 mg every 3 months.
Common side effects
- Injection-site pain, redness, or swelling
- Rash or itching
Important warnings
- Serious allergic reactions can occur, sometimes delayed.
- Use caution with severe allergic reactions to fremanezumab or its ingredients.
Pregnancy
Human pregnancy data are limited; discuss use with a healthcare professional.
Breastfeeding
It is unknown whether fremanezumab passes into breast milk; human data are limited.
Interactions
- No established clinically important drug interactions are known.
AI-generated from general medical knowledge, not from this product's official leaflet. It may be incomplete or out of date. Not medical advice — ask a pharmacist or doctor before making any decision.